THY1 and neoplasm: rWISP-1 also blocked signaling pathway activation and the protein expression of MMP2 and MMP12 in CD326+ tumor cells (Fig. 10k and Supplementary Fig. S14c) and reduced the mRNA expression levels of CAF activation markers in Thy1+ CAFs (Fig. 10l).